Our latest case study details how Antidote developed a customized outreach strategy that delivered on our client’s hemophilia patient recruitment goal in just one month.

In our latest whitepaper, we examine what post-COVID clinical research catch-up looks like.

A new take on Antidote’s precision recruitment approach worked quickly for a pharmaceutical client looking for patients with CICP.

Clinical trial recruitment challenges include patient concerns about safety, protocol complexity, and lack of clinical trial awareness.

Antidote’s “calibration model” involves an upfront flat fee paid by the sponsor to measure the per-patient cost for recruitment prior to executing a contract for recruitment at scale.

As treatments become more targeted, so do clinical trials. It can feel like it’s never been more difficult to recruit patients to take part in clinical trials than it is today. This difficulty is tied to clinical trial protocol complexity.

An atopic dermatitis case study that proves the efficacy of Antidote's precision recruitment model.

We're thrilled to share that our CEO, Laurent Schockmel, has been named a Top 40 Healthcare Transformer by MM&M.

We caught up with Keith Lovell to talk about his reasons for joining Antidote, his thoughts on managing a small company versus a large one, and the business principles that he lives by.

There are effective ways to meet your trial quotas on time and on budget. Here’s how precision recruitment addresses some of the biggest issues facing researchers today.

It’s with great excitement that we share that we have officially partnered with PWNHealth, a virtual care company that enables patient access to diagnostic testing, treatment, and professional guidance, to bolster efficiencies in our clinical trial recruitment by incorporating direct-to-patient lab services.